Abstract
Breast cancer is the most common cancer diagnosed in women, both in the UK and worldwide. A small proportion of women are at very high risk of breast cancer, having a particularly strong family history. The National Institute for Health and Clinical Excellence (NICE) has advised that practitioners should not, in most instances, actively seek to identify women with a family history of breast cancer. An audit was undertaken at an urban primary care practice of 15,000 patients, using a paper-based, self-administered questionnaire sent to patients identified with a personal history of breast cancer. The aim of this audit was to determine whether using targeted screening of relatives of patients with breast cancer to identify familial cancer risk is worthwhile in primary care. Since these patients might already expected to have been risk assessed following their initial diagnosis, this audit acts as a quality improvement exercise. The audit used a validated family history questionnaire and risk assessment tool as a screening approach for identifying and grading familial risk in line with the NICE guidelines, to guide referral to the familial cancer screening service. The response rate to family history questionnaires was 54 % and the majority of patients responded positively to their practitioner seeking to identify familial cancer risks in their family. Of the 57 returned questionnaires, over a half (54 %) contained pedigrees with individuals eligible for referral. Patients and their relatives who are often registered with the practice welcome the discussion. An appropriate referral can therefore be made. The findings suggest a role for primary care practitioners in the identification of those at higher familial risk. However integrated systems and processes need designing to facilitate this work.
Similar content being viewed by others
References
Cancer Research UK, www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/incidence/ukbreast-cancer-incidence-statistics, Accessed 1st December 2012 and 12th March 2014
Cancer Research UK, www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/riskfactors, Accessed 1st December 2012 and 12th March 2014
NICE clinical guideline 41 (partial update of NICE clinical guideline 14): Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care (October 2006). National Collaborating Centre for Primary Care. www.nice.org.uk
NICE clinical guideline 41 (partial update of NICE clinical guideline 14), quick reference guide (N1130): Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care (October 2006). www.nice.org.uk
McIntosh A, Shaw C, Evans G, et al (2004 updated 2006). Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer. National Collaborating Centre Page 5 of 5 for Primary Care/University of Sheffield, London. NICE guideline CG041. www.nice.org.uk
Familial breast cancer: Evidence Update May 2012. A summary of selected new evidence relevant to NICE clinical guideline 41 ‘The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care’, 2006. www.nice.org.uk
Harris H, Nippert I, Julian-Reynier C et al (2011) Familial breast cancer: is it time to move from a reactive to a proactive role? Fam Cancer 10:501–503
Clark AS, Domchek SM (2011) Clinical management of hereditary breast cancer syndromes. J Mammary Gland Biol Neoplasia 16(1):17–25
FH01 collaborative teams (2010) Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 11(12):1127–1134
NICE clinical guideline 164: Familial breast cancer: Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer, 2013. www.nice.org.uk
Qureshi N et al (2005) Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract 1–7
Hughes KS, Roche C, Campbell CT et al (2003) Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. Breast J 9(1):19–25
Kohut K et al (2012) Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London. Fam Cancer 11:107–113
Emery J et al (2000) Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. BMJ 321(7252):28–32
Velicer CM, Taplin SMPH (2001) Genetic testing for breast cancer: where are health care providers in the decision process? Genet Med 3(2):112–119
Grande GE et al (2002) Women’s views of consultations about familial risk of breast cancer in primary care. Patient Educ Couns 48(3):275–282
de Bock GH et al (1999) The assessment of genetic risk of breast cancer: a set of GP guidelines. Fam Pract 16(1):71–77
Acheson LS (2011) Recording, interpreting, and updating the family history of cancer: implications for cancer prevention. JAMA 306(2):208–210
Ziogas A et al (2011) Clinically relevant changes in family history of cancer over time. JAMA 306(2):172–178
Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377:127–138
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nathan, P., Ahluwalia, A. & Chorley, W. A primary care audit of familial risk in patients with a personal history of breast cancer. Familial Cancer 13, 591–594 (2014). https://doi.org/10.1007/s10689-014-9737-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-014-9737-0